The impact of abiraterone acetate (AA) therapy on patient-reported pain and functional status in chemotherapy-naive patients with progressive, metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Basch, E.; Ryan, C. J.; Kheoh, T.; Fizazi, K.; Logothetis, C. J.; Rathkopf, D. E.; Smith, M. R.; Mainwaring, P. N.; Hao, Y.; Griffin, T.; Li, S.; Meyers, M.; Molina, A.; Cleeland, C.
Abstract Title:	The impact of abiraterone acetate (AA) therapy on patient-reported pain and functional status in chemotherapy-naive patients with progressive, metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title:	37th Congress of the European Society for Medical Oncology (ESMO)
Journal Title:	Annals of Oncology
Volume:	23
Issue:	Suppl. 9
Meeting Dates:	2012 Sep 28-Oct 2
Meeting Location:	Vienna, Austria
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2012-09-01
Start Page:	ix295
Language:	English
ACCESSION:	WOS:000309409001376
PROVIDER:	wos
PUBMED:	23012731
DOI:	10.1093/annonc/mds400
Notes:	Meeting Abstract: 895O -- "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/37180